openPR Logo
Press release

Activin Receptor Type 1 Key players- Blueprint Medicines Corp,Daiichi Sankyo Company Ltd,La Jolla Pharmaceutical Company and Oncodesign SA Market study and Forecast 2017

04-11-2018 11:21 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: WISEGUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Activin Receptor Type 1 Key players- Blueprint Medicines

Activin Receptor Type 1

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1473959-histone-lysine-n-methyltransferase-ehmt2-euchromatic-histone-lysine-n-methyltransferase-2

Summary 

Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The latest report Activin Receptor Type 1 - Pipeline Review, H1 2017, outlays comprehensive information on the Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

 

Scope of the Report

- The report provides a snapshot of the global therapeutic landscape for Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) 
- The report reviews Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 

  Table of Contents 

List of Tables 
List of Figures 
Introduction 
Global Markets Direct Report Coverage 
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Overview 
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Therapeutics Development 
Products under Development by Stage of Development 
Products under Development by Therapy Area 
Products under Development by Indication 
Products under Development by Companies 
Products under Development by Universities/Institutes 
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF B Superfamily Receptor Type I or ALK2 or ACVR1 or EC 2.7.11.30) - Therapeutics Assessment 
Assessment by Mechanism of Action 
Assessment by Route of Administration 
Assessment by Molecule Type 
Activin Receptor Type 1 (Activin Receptor Like Kinase 2 or Serine/Threonine Protein Kinase Receptor R1 or TGF     

  .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1473959-histone-lysine-n-methyltransferase-ehmt2-euchromatic-histone-lysine-n-methyltransferase-2

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Activin Receptor Type 1 Key players- Blueprint Medicines Corp,Daiichi Sankyo Company Ltd,La Jolla Pharmaceutical Company and Oncodesign SA Market study and Forecast 2017 here

News-ID: 1011395 • Views: 308

More Releases from WISEGUY RESEARCH CONSULTANTS PVT LTD

Food Thickeners Market 2020 Segmentation, Trends, Industry Research and more….
Food Thickeners Market This recently published report on international Food Thickeners Market has been prepared upon conducting an extensive study on various aspects associated. It makes the potential growth rate of the market and provides the predictive reports that can be taken in to account for the forecast period of in-between 2020 and 2025. Probability of the market, as provided in the report, has been made in accordance with the information
Data Masking Software Market By Services,Assets Type,Solutions,End-Users,Applica …
WiseGuyReports.Com Publish a New Market Research Report On –“ Data Masking Software Market By Services,Assets Type,Solutions,End-Users,Applications,Regions Forecasts To 2026”. Data Masking Software Market 2020 Description: - The global Data Masking Software market has a higher potential for dealing with the business needs of several industries and organizations. They have products listed under their market to give enhanced functionality to the industries to help them earn their profitable outcome. The products listed under the
Patient Data Management Systems Market Segmentation, Application, Trends, Opport …
WiseGuyReports.Com Publish a New Market Research Report On –“ Patient Data Management Systems Market Segmentation, Application, Trends, Opportunity & Forecast 2020 To 2026”. Patient Data Management Systems Market 2020 Description: - The global Patient Data Management Systems market has a higher potential for dealing with the business needs of several industries and organizations. They have products listed under their market to give enhanced functionality to the industries to help them earn their profitable
Rotavirus Vaccine Market 2020 Global Share,Trend,Segmentation And Forecast To 20 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Rotavirus Vaccine Market 2020 Global Share,Trend,Segmentation And Forecast To 2026”. Rotavirus Vaccine Market 2020 Description: - The global Rotavirus Vaccine market has a higher potential for dealing with the business needs of several industries and organizations. They have products listed under their market to give enhanced functionality to the industries to help them earn their profitable outcome. The products listed under the market are

All 5 Releases


More Releases for Receptor

Interleukin Receptor Modulators Therapeutics - Pipeline Analysis 2019
Interleukin receptors are a group of cytokine receptors that are expressed by leukocytes. Interleukin receptors play an important role in the functioning of the immune system. However, with complete knowledge of their role in pathogenesis of different diseases from allergic reactions to autoimmune disorders and even cancer makes these interleukin receptors an attractive target among different available treatment modalities. Download the sample report @ https://www.pharmaproff.com/request-sample/1204 Immune-modulatory role of interleukins as well
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) …
"The Report Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1)-Lysophosphatidic acid receptor 1 is a G protein-coupled receptor that binds the lipid signaling molecule lysophosphatidic acid (LPA). Lysophosphatidic acid (LPA) receptor belongs to a group known as
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Gh …
"The Report Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR)-Growth hormone secretagogue receptor (GHSR) also known as ghrelin receptor, is a G protein-coupled receptor that binds ghrelin. Ghrelin is
Estrogen Receptor Market Pipeline Review, H2 2017
"The Report Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) pipeline Target constitutes close to 22 molecules.
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipe …
"The Report Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10